TENXTenax Therapeutics

Median target
$5
calls from the last 12 months
Implied return
+168.8%
median target vs. price
Coverage
7 analysts · 7 calls
updated in the last 12 months
Consensus
4/3/0+4 net
Buy / Hold / Sell

Which analysts are behind TENX's consensus?

See every current rating, price target and the analysts' track records for Tenax Therapeutics — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 7 analysts with calls on TENX updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

TENX elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-09-16InsidersDoogan DeclanDirectorInsider purchase53.0K sh @ $1.92$102K
2026-09-15InsidersGiordano Christopher ThomasCEOInsider purchase4.8K sh @ $1.82$9K
2026-09-11InsidersGiordano Christopher ThomasCEOInsider purchase6.0K sh @ $1.88$11K
2026-09-11InsidersStaab Thomas R IiChief Financial OfficerInsider purchase5.7K sh @ $1.94$11K
2026-09-03InsidersAdar1 Capital Management, Llc +110% ownerInsider purchase900.0K sh @ $1.78$1.6M
2026-09-02InsidersAdar1 Capital Management, Llc +110% ownerInsider purchase187.7K sh @ $1.80$338K
2026-09-01InsidersAdar1 Capital Management, Llc +110% ownerInsider purchase179.1K sh @ $1.80$322K
2026-08-31InsidersAdar1 Capital Management, Llc +110% ownerInsider purchase403.6K sh @ $1.79$723K
2026-08-24InsidersAdar1 Capital Management, Llc +110% ownerInsider purchase107.4K sh @ $1.75$188K
2026-08-21InsidersAdar1 Capital Management, Llc +110% ownerInsider purchase716.4K sh @ $1.77$1.3M

More: insider activity · executive branch · trending